Dare Bioscience, Inc. Fair Value Adjustment of Warrants
Dare Bioscience, Inc. (DARE) reported Fair Value Adjustment of Warrants of -$504.00 thousand for the 12-month period ending 2014-12-31, per its 10-K/A filed 2017-06-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2017-06-13
- Dare Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2014-06-30 was $0.00.
- Dare Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2014-03-31 was -$504.00K.
- Dare Bioscience, Inc. fair value adjustment of warrants for fiscal 2014 was -$504.00K.
- Dare Bioscience, Inc. fair value adjustment of warrants for fiscal 2013 was -$202.00K.
- Dare Bioscience, Inc. fair value adjustment of warrants for fiscal 2012 was -$39.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 100 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $0.00 derived: sum of 2 quarters · filed 2017-06-13 | $0.00 derived: sum of 3 quarters · filed 2017-06-13 | -$504.00K 10-K/A · filed 2017-06-13 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | -$504.00K 10-Q · filed 2015-11-16 | -$462.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-K 3 month · filed 2015-08-06 | -$504.00K 10-Q · filed 2015-08-06 | -$462.00K derived: sum of 3 quarters · filed 2016-03-10 | -$455.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-03-31 | -$504.00K 10-K · filed 2016-03-10 | -$462.00K derived: sum of 2 quarters · filed 2016-03-10 | -$455.00K derived: sum of 3 quarters · filed 2016-03-10 | -$475.00K derived: sum of 4 quarters · filed 2016-03-10 | -$719.00K 10-Q · filed 2014-05-27 |
| 2013-12-31 | $42.00K 10-K · filed 2015-03-19 | $49.00K derived: sum of 2 quarters · filed 2015-03-19 | $29.00K derived: sum of 3 quarters · filed 2015-03-19 | -$202.00K 10-K · filed 2016-03-10 | |
| 2013-09-30 | $7.00K 10-K · filed 2015-03-19 | -$13.00K derived: sum of 2 quarters · filed 2015-03-19 | -$244.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | -$20.00K 10-K · filed 2015-03-19 | -$251.00K 10-Q · filed 2014-08-12 | |||
| 2013-03-31 | -$231.00K 10-K · filed 2015-03-19 | ||||
| 2012-12-31 | -$39.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |